Healthcare · Drug Manufacturers - Specialty & Generic
No live calls today · full consensus board · no graded calls yet
Price (daily close, 2026-10-23)
Trailing returns (daily closes)
Recent news
| 2026-10-24 | Expert Publication On PWS Treatment Could Be A Game Changer For Neurocrine Biosciences (NBIX) · yf_tkr_NBIX |
| 2026-10-23 | Neurocrine Biosciences (NBIX) Starts Phase 2 Alzheimer’s Trial · yf_tkr_NBIX |
| 2026-10-22 | Neurocrine Biosciences Announces Publication in Orphanet Journal of Rare Diseases Advancing Understanding of Hyperphagia in Prader-Willi Syndrome · pr_newswire_finance |
| 2026-10-20 | Neurocrine Biosciences Initiates Phase 2 Clinical Study Evaluating NBI-'567 in Adults with Alzheimer's Disease · yf_tkr_NBIX |
How grading works: every call is locked before the open and scored on the session's open→close move — see the methodology.
Open Fortivio.AI →Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。